Halios, Neneta B.

HRN: 08-50-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/20/2026
07/20/2026
IV
LD
Now
Urosepsis
Checking Final Appropriateness 
07/20/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/20/2026
07/27/2026
IV
2.25g
Q6
Urosepsis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: